Literature DB >> 10428224

One- or two-stage bilateral total hip replacement.

J Alfaro-Adrián1, F Bayona, J A Rech, D W Murray.   

Abstract

It is not clear whether bilateral hip replacement should be done in 1 or 2 stages. The total number of total hip replacements (THRs) done in our center between 1989 and 1995 was approximately 4,000. The number of hips that were bilateral was 404, or 9% of the total number of THRs performed during this time period. Of these bilateral hip replacements, 190 (95 patients) were done as a 1-stage procedure, whereas 214 (107 patients) were done in 2 stages with 2 to 24 months in between the operations. In contrast to previous studies, there were no significant preoperative differences between the 2 groups of patients having 1-stage or 2-stage THRs, and, in particular, the comorbidity assessed by the American Society of Anesthesiologists (ASA) grade was not significantly different. Our results demonstrate that, in our patient population, bilateral THR was equally safe whether performed as a 1-stage or 2-stage procedure. This was the case in the low-risk (ASA 1 and 2) and high-risk (ASA 3 and 4) patient subgroups. One-stage bilateral THR is cheaper and involves less time in the hospital.

Entities:  

Mesh:

Year:  1999        PMID: 10428224     DOI: 10.1016/s0883-5403(99)90099-2

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  27 in total

1.  Simultaneous bilateral hip replacement reveals superior outcome and fewer complications than two-stage procedures: a prospective study including 1819 patients and 5801 follow-ups from a total joint replacement registry.

Authors:  Emin Aghayev; Andreas Beck; Lukas P Staub; Daniel Dietrich; Markus Melloh; Weniamin Orljanski; Christoph Röder
Journal:  BMC Musculoskelet Disord       Date:  2010-10-25       Impact factor: 2.362

Review 2.  Bilateral endoprosthetic total hip or knee arthroplasty.

Authors:  Joachim Pfeil; Philip Höhle; Philipp Rehbein
Journal:  Dtsch Arztebl Int       Date:  2011-07-08       Impact factor: 5.594

3.  Hospital readmission rates following primary total hip arthroplasty: present and future in sight.

Authors:  José Lamo-Espinosa; Elena Pascual-Roquet Jalmar
Journal:  Ann Transl Med       Date:  2015-05

Review 4.  Simultaneous bilateral total hip arthroplasties in nonagenarians.

Authors:  F R Power; D T Cawley; P D Curtin
Journal:  Ir J Med Sci       Date:  2017-02-09       Impact factor: 1.568

5.  Simultaneous bilateral total hip arthroplasties do not lead to higher complication or allogeneic transfusion rates compared to unilateral procedures.

Authors:  Sergio Romagnoli; Sara Zacchetti; Paolo Perazzo; Francesco Verde; Giuseppe Banfi; Marco Viganò
Journal:  Int Orthop       Date:  2013-07-24       Impact factor: 3.075

6.  Clinical and radiological short-term complications after single-stage bilateral uncemented total hip arthroplasty.

Authors:  J Lamo-Espinosa; S Troncoso; A Valentí-Azcárate; P Díaz de Rada; J R Valentí-Nín
Journal:  Musculoskelet Surg       Date:  2014-11-27

7.  Are there benefits to one- versus two-stage procedures in bilateral hip resurfacing?

Authors:  Harlan C Amstutz; Edwin P Su; Michel J Le Duff; Vincent A Fowble
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

8.  One-stage versus 2-stage bilateral total joint arthroplasty: a matched cohort study.

Authors:  Raghav Saini; James Powell; Rajrishi Sharma; Shannon Puloski; Saboura Mahdavi; Christopher Smith; Kelly Johnston
Journal:  Can J Surg       Date:  2020-04-17       Impact factor: 2.089

9.  Safety of Single-Stage Bilateral Direct Anterior Approach Total Hip Arthroplasty Performed in All Eligible Patients at a Honolulu Hospital.

Authors:  Gregory J Harbison; Samantha N Andrews; Cass K Nakasone
Journal:  Hawaii J Health Soc Welf       Date:  2020-03-01

10.  Vacuum-assisted closure in the treatment of early hip joint infections.

Authors:  Jens Kelm; Eduard Schmitt; Konstantinos Anagnostakos
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.